GlassScriptPhysician profile
Carson T Kaeser
NPI 1992064539
$10,167.84
in general payments reported to CMS, 2019-2025
22 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $1,239 · 2021: $164 · 2022: $4,418 · 2023: $2,022 · 2024: $652 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,190 · Travel and Lodging: $529 · Honoraria: $295 · Education: $90.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,190.20 |
| Travel and Lodging | $529.31 |
| Honoraria | $295.13 |
| Education | $90.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $5,423.03 | 2022-2024 | Axonics, Bulkamid |
| Medtronic USA, INC. | $2,108.97 | 2019-2020 | |
| Boston Scientific Corporation | $1,493.87 | 2019-2025 | Solyx Sis System, Upsylon, Axonics |
| Astellas Pharma US INC | $320.99 | 2019-2024 | Veozah |
| Medtronic, INC. | $240.99 | 2021-2025 | Altaviva |
| Coloplast Corp | $129.86 | 2019-2020 | |
| Abbvie INC. | $118.68 | 2021-2024 | |
| Organon LLC | $46.02 | 2024 | |
| Laborie Medical Technologies Corp. | $43.51 | 2023-2024 | Urgent PC Neuromodulation System |
| Sumitomo Pharma America, INC. | $36.73 | 2023-2024 | Myfembree, Gemtesa |
| Merck Sharp & Dohme LLC | $30.36 | 2019 | |
| Channel Medsystems, INC. | $26.96 | 2023 | |
| Integra Lifesciences Corporation | $21.11 | 2025 | Tenoglide |
| Escala Medical INC. | $17.31 | 2024 | |
| Mallinckrodt Enterprises LLC | $15.22 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.85 | 2020 | |
| Urovant Sciences INC | $14.76 | 2022 | |
| Smith+Nephew, INC. | $14.50 | 2019 | |
| Therapeuticsmd, INC. | $14.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.41 | 2021 | |
| Allergan, INC. | $11.25 | 2020 | |
| Renovia INC | $11.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carson Kaeser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.